BioRem Inc. (TSXV:BRM)
Canada · Delayed Price · Currency is CAD 3.270
+0.070 (2.19%)
May 1, 2026, 3:59 PM EST
BioRem Earnings Call Transcripts
Fiscal Year 2025
-
Management reduced outstanding shares by 60% through a strategic buyback, strengthening capital structure. The business is experiencing strong organic growth, driven by new products and services, with a record backlog and expanding service revenue. Market demand is supported by infrastructure upgrades, regulatory trends, and a disciplined M&A approach.